COVID Intel - by Dr.William Makis

COVID Intel - by Dr.William Makis

Share this post

COVID Intel - by Dr.William Makis
COVID Intel - by Dr.William Makis
MEBENDAZOLE kills Ovarian Cancer Cells that are resistant to Chemotherapy - once again, a cheap anti-parasitic outperforms a $500 million key chemotherapy agent
Copy link
Facebook
Email
Notes
More

MEBENDAZOLE kills Ovarian Cancer Cells that are resistant to Chemotherapy - once again, a cheap anti-parasitic outperforms a $500 million key chemotherapy agent

Dr. William Makis MD's avatar
Dr. William Makis MD
Aug 25, 2024
∙ Paid
160

Share this post

COVID Intel - by Dr.William Makis
COVID Intel - by Dr.William Makis
MEBENDAZOLE kills Ovarian Cancer Cells that are resistant to Chemotherapy - once again, a cheap anti-parasitic outperforms a $500 million key chemotherapy agent
Copy link
Facebook
Email
Notes
More
36
30
Share

Keep reading with a 7-day free trial

Subscribe to COVID Intel - by Dr.William Makis to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Dr. William Makis MD
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More